Hendrik Van Poppel1, Steven Joniau. 1. Department of Urology, University Hospital, K.U. Leuven, Leuven, Belgium. Hendrik.VanPoppel@uz.kuleuven.ac.be
Abstract
OBJECTIVES: To clarify the role of radical prostatectomy (RP) in the treatment of locally advanced and high-grade prostate cancer. METHODS: Literature search of Medline publications on surgery for locally advanced and high-grade prostate cancer. RESULTS: In patients with locally advanced disease, the cancer-specific survival rate after RP at 5- and 10-yr follow-up was 85-100% and 57-91.6%, respectively. The overall survival rate at 5 and 10 yr was>75% and 60%, respectively. In patients with high-grade prostate cancer (Gleason score> or =8), the biochemical recurrence-free survival after RP at 5 and 10 yr of follow-up was 51% and 39%, respectively. Nomograms and modern imaging techniques are useful in predicting pathologic stage, presence of positive lymph nodes, or seminal vesicle involvement. These allow physicians to recognise those patients with locally advanced disease who are most likely to benefit from surgical treatment. Downgraded and organ- or specimen-confined high-grade tumours can have a good prognosis after surgery. The prostate-specific antigen value and the percent positive biopsy cores can be helpful in identifying men with high-grade prostate cancer most likely to benefit from RP. CONCLUSIONS: It is likely that surgery has a role in the treatment of locally advanced and high-grade tumours. However, it is necessary and urgent to have randomised trials assessing survival and quality of life when RP is and is not included in the multimodality treatment.
OBJECTIVES: To clarify the role of radical prostatectomy (RP) in the treatment of locally advanced and high-grade prostate cancer. METHODS: Literature search of Medline publications on surgery for locally advanced and high-grade prostate cancer. RESULTS: In patients with locally advanced disease, the cancer-specific survival rate after RP at 5- and 10-yr follow-up was 85-100% and 57-91.6%, respectively. The overall survival rate at 5 and 10 yr was>75% and 60%, respectively. In patients with high-grade prostate cancer (Gleason score> or =8), the biochemical recurrence-free survival after RP at 5 and 10 yr of follow-up was 51% and 39%, respectively. Nomograms and modern imaging techniques are useful in predicting pathologic stage, presence of positive lymph nodes, or seminal vesicle involvement. These allow physicians to recognise those patients with locally advanced disease who are most likely to benefit from surgical treatment. Downgraded and organ- or specimen-confined high-grade tumours can have a good prognosis after surgery. The prostate-specific antigen value and the percent positive biopsy cores can be helpful in identifying men with high-grade prostate cancer most likely to benefit from RP. CONCLUSIONS: It is likely that surgery has a role in the treatment of locally advanced and high-grade tumours. However, it is necessary and urgent to have randomised trials assessing survival and quality of life when RP is and is not included in the multimodality treatment.
Authors: Joo Yong Lee; Ho Won Kang; Koon Ho Rha; Nam Hoon Cho; Young Deuk Choi; Sung Joon Hong; Kang Su Cho Journal: J Cancer Res Clin Oncol Date: 2015-12-12 Impact factor: 4.553
Authors: Jonas Busch; Ahmed Magheli; Natalia Leva; Stefan Hinz; Michelle Ferrari; Frank Friedersdorff; Tom Florian Fuller; Kurt Miller; Mark L Gonzalgo Journal: World J Urol Date: 2014-03-09 Impact factor: 4.226
Authors: Phillip M Pierorazio; Jeffrey K Mullins; John B Eifler; Kipp Voth; Elias S Hyams; Misop Han; Christian P Pavlovich; Trinity J Bivalacqua; Alan W Partin; Mohamad E Allaf; Edward M Schaeffer Journal: BJU Int Date: 2013-01-28 Impact factor: 5.588
Authors: Mauro Gacci; Alchiede Simonato; Lorenzo Masieri; John L Gore; Michele Lanciotti; Annalisa Mantella; Mario Alberto Rossetti; Sergio Serni; Virginia Varca; Andrea Romagnoli; Carlo Ambruosi; Fabio Venzano; Marco Esposito; Tomaso Montanaro; Giorgio Carmignani; Marco Carini Journal: Health Qual Life Outcomes Date: 2009-11-13 Impact factor: 3.186